- Home
- Products
- Customized FluoroAb™
- C5
- Anti-C5 MAb (Clone 21)-iFluor® 430 Succinimidyl Ester
Anti-C5 MAb (Clone 21)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS3206)
This product is comprised of an Humanized Anti-C5 IgG2-G4-kappa (Clone 21) labeled with iFluor® 430 Succinimidyl Ester. iFluor® 430 Succinimidyl Ester is a Green-fluorescent dye and it's excitation/emission is 403/427 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- C5
- Alternative Names
- C5; complement component 5; complement C5; CPAMD4; anaphylatoxin C5a analog; C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4; FLJ17816; FLJ17822; MGC142298;
- Overview
- This gene encodes a component of the complement system, a part of the innate immune system that plays an important role in inflammation, host homeostasis, and host defense against pathogens. The encoded preproprotein is proteolytically processed to generate multiple protein products, including the C5 alpha chain, C5 beta chain, C5a anaphylatoxin and C5b. The C5 protein is comprised of the C5 alpha and beta chains, which are linked by a disulfide bridge. Cleavage of the alpha chain by a convertase enzyme results in the formation of the C5a anaphylatoxin, which possesses potent spasmogenic and chemotactic activity, and the C5b macromolecular cleavage product, a subunit of the membrane attack complex (MAC). Mutations in this gene cause complement component 5 deficiency, a disease characterized by recurrent bacterial infections. Alternative splicing results in multiple transcript variants.
- Overview
- Humanized Anti-C5 IgG2-G4-kappa (Clone 21)
- Species Reactivity
- Human
- Name
- iFluor® 430 Succinimidyl Ester
- Color
- Green
- Excitation⁄Emission (nm)
- 433/498
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-C-kit MAb (Clone 1)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS267)
- Anti-PDCD1 MAb (Clone 27)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS10701)
- Anti-F3 MAb (Clone 4)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS7939)
- Anti-PCSK9 MAb (Clone 5)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8480)
- Gantenerumab-iFluor 488 (CAT#: ADC-FL-093)
- Anti-CD4 MAb (Clone 30)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS1163)
- Anti-FOLR1 MAb (Clone 7)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8690)
- Anti-CD33 MAb (Clone 11)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11633)
- Tucotuzumab-iFluor 568 (CAT#: ADC-FL-1285)
- Visilizumab-iFluor 750 (CAT#: ADC-FL-587)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS3206. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-735 | Anti-C5 (Pexelizumab)-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
| ADC-W-728 | Anti-C5 (Eculizumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-739 | Anti-C5 (Pexelizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| ADC-W-734 | Anti-C5 (Pexelizumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-738 | Anti-C5 (Pexelizumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
